LIVN has been the subject of several other reports. Jefferies Group LLC started coverage on LivaNova PLC in a report on Friday, September 8th. They set a buy rating and a $76.00 target price for the company. Piper Jaffray Companies reissued an overweight rating and issued a $75.00 price objective on shares of LivaNova PLC in a research note on Tuesday. BidaskClub downgraded LivaNova PLC from a strong-buy rating to a buy rating in a research note on Monday, July 24th. WBB Securities downgraded LivaNova PLC from a hold rating to a sell rating and set a $50.00 price objective for the company. in a research note on Tuesday, August 15th. Finally, Berenberg Bank reissued a buy rating and issued a $70.00 price objective on shares of LivaNova PLC in a research note on Friday, August 11th. One analyst has rated the stock with a sell rating, three have assigned a hold rating and four have given a buy rating to the stock. The company currently has a consensus rating of Hold and a consensus target price of $68.67.
LivaNova PLC (LIVN) traded up 0.51% during mid-day trading on Friday, reaching $68.42. The company’s stock had a trading volume of 944,452 shares. LivaNova PLC has a 1-year low of $40.83 and a 1-year high of $69.29. The firm has a 50-day moving average of $62.55 and a 200 day moving average of $57.59. The firm has a market capitalization of $3.34 billion, a price-to-earnings ratio of 122.18 and a beta of 0.58.
LivaNova PLC (NASDAQ:LIVN) last announced its earnings results on Wednesday, August 9th. The company reported $1.01 EPS for the quarter, beating the consensus estimate of $0.82 by $0.19. LivaNova PLC had a return on equity of 9.08% and a net margin of 2.26%. The business had revenue of $321.40 million during the quarter, compared to the consensus estimate of $315.75 million. LivaNova PLC’s quarterly revenue was up .1% on a year-over-year basis. Equities analysts expect that LivaNova PLC will post $3.24 earnings per share for the current year.
WARNING: “LivaNova PLC (LIVN) Upgraded to “Buy” at Needham & Company LLC” was originally posted by Transcript Daily and is the sole property of of Transcript Daily. If you are viewing this news story on another site, it was illegally copied and republished in violation of U.S. and international copyright & trademark legislation. The original version of this news story can be accessed at https://transcriptdaily.com/2017/09/16/livanova-plc-livn-upgraded-to-buy-at-needham-company-llc.html.
In related news, Director Daniel Jeffrey Moore sold 1,000 shares of the stock in a transaction dated Tuesday, August 15th. The stock was sold at an average price of $60.76, for a total value of $60,760.00. Following the completion of the sale, the director now directly owns 58,296 shares of the company’s stock, valued at approximately $3,542,064.96. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 0.28% of the stock is currently owned by corporate insiders.
Several institutional investors and hedge funds have recently bought and sold shares of LIVN. Capstone Asset Management Co. purchased a new stake in shares of LivaNova PLC during the 1st quarter worth about $233,000. Glen Harbor Capital Management LLC raised its stake in shares of LivaNova PLC by 11.4% during the 1st quarter. Glen Harbor Capital Management LLC now owns 2,992 shares of the company’s stock worth $147,000 after purchasing an additional 306 shares in the last quarter. Oregon Public Employees Retirement Fund raised its stake in shares of LivaNova PLC by 1.3% during the 1st quarter. Oregon Public Employees Retirement Fund now owns 15,360 shares of the company’s stock worth $753,000 after purchasing an additional 200 shares in the last quarter. American Century Companies Inc. raised its stake in shares of LivaNova PLC by 232.5% during the 1st quarter. American Century Companies Inc. now owns 49,869 shares of the company’s stock worth $2,444,000 after purchasing an additional 34,872 shares in the last quarter. Finally, Bank of New York Mellon Corp raised its stake in shares of LivaNova PLC by 5.1% during the 1st quarter. Bank of New York Mellon Corp now owns 374,488 shares of the company’s stock worth $18,353,000 after purchasing an additional 18,042 shares in the last quarter. 82.36% of the stock is owned by institutional investors.
About LivaNova PLC
LivaNova PLC is a medical device company focused on the development and delivery of therapeutic solutions. The Company’s segments include Cardiac Surgery, Cardiac Rhythm Management, Neuromodulation and Other. The Cardiac Surgery segment is engaged in the development, production and sale of cardiovascular surgery products.
Receive News & Ratings for LivaNova PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LivaNova PLC and related companies with MarketBeat.com's FREE daily email newsletter.